The current study focuses on [1] determining whether anti-vinculin autoantibodies provide insight into a diagnosis of SSc and [2] comparing serum anti-vinculin antibody levels in two SSc patient groups, namely, PAH-predominant and IPF-predominant groups. Here, VCL is linked to systemic sclerosis.